The stock of Nexalin Technology Inc (NXL) has seen a -11.73% decrease in the past week, with a 25.90% gain in the past month, and a -16.84% decrease in the past quarter. The volatility ratio for the week is 12.76%, and the volatility levels for the past 30 days are at 14.19% for NXL. The simple moving average for the past 20 days is 3.79% for NXL’s stock, with a 64.80% simple moving average for the past 200 days.
Is It Worth Investing in Nexalin Technology Inc (NASDAQ: NXL) Right Now?
Company’s 36-month beta value is 4.27.Analysts have differing opinions on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 1 as “hold,” and 0 as “sell.”
The public float for NXL is 10.44M, and currently, short sellers hold a 4.87% ratio of that floaft. The average trading volume of NXL on February 13, 2025 was 544.04K shares.
NXL) stock’s latest price update
Nexalin Technology Inc (NASDAQ: NXL) has experienced a decline in its stock price by -6.51 compared to its previous closing price of 3.38. However, the company has seen a fall of -11.73% in its stock price over the last five trading days. globenewswire.com reported 2025-02-10 that HOUSTON, TEXAS, Feb. 10, 2025 (GLOBE NEWSWIRE) — Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) the leader in Deep Intracranial Frequency Stimulation (DIFS™) of the brain, announces its appointment as Industry Co-Chair of the National Traumatic Brain Injury (TBI) Registry Coalition. This appointment emphasizes Nexalin’s commitment to advancing TBI advocacy and research, particularly in collaboration with policymakers and stakeholders in Washington, D.C.
NXL Trading at -3.03% from the 50-Day Moving Average
After a stumble in the market that brought NXL to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -29.62% of loss for the given period.
Volatility was left at 14.19%, however, over the last 30 days, the volatility rate increased by 12.76%, as shares surge +13.67% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -26.00% lower at present.
During the last 5 trading sessions, NXL fell by -11.73%, which changed the moving average for the period of 200-days by +128.16% in comparison to the 20-day moving average, which settled at $3.04. In addition, Nexalin Technology Inc saw 14.49% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at NXL starting from Owens David, who purchase 1,000 shares at the price of $3.10 back on Feb 04 ’25. After this action, Owens David now owns 155,793 shares of Nexalin Technology Inc, valued at $3,100 using the latest closing price.
Owens David, the Chief Medical Officer of Nexalin Technology Inc, purchase 1,000 shares at $2.98 during a trade that took place back on Feb 04 ’25, which means that Owens David is holding 154,793 shares at $2,980 based on the most recent closing price.
Stock Fundamentals for NXL
Current profitability levels for the company are sitting at:
- -40.13 for the present operating margin
- -5.73 for the gross margin
The net margin for Nexalin Technology Inc stands at -34.27. The total capital return value is set at -1.31. Equity return is now at value -135.57, with -114.63 for asset returns.
Currently, EBITDA for the company is -5.69 million with net debt to EBITDA at 0.01. When we switch over and look at the enterprise to sales, we see a ratio of 250.26. The receivables turnover for the company is 10.68for trailing twelve months and the total asset turnover is 0.03. The liquidity ratio also appears to be rather interesting for investors as it stands at 16.39.
Conclusion
In a nutshell, Nexalin Technology Inc (NXL) has experienced a mixed performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
